Neutralization of IL-17 inhibits the production of anti-ANT autoantibodies in CVB3-induced acute viral myocarditis

International Immunopharmacology

Volumn 10, Issue 3, 2010, Pages 272-276

  Yuan, Jing ^a   Yu, Miao ^a   Lin, Qiong Wen ^a   Cao, Ai Lin ^a   Yu, Xian ^a   Dong, Ji Hua ^b   Wang, Jin Ping ^b   Zhang, Jing Hui ^b   Wang, Min ^a   Guo, He Ping ^a   Liao, Yu Hua ^a  

^a Union Hospital   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute viral myocarditis; ANT; Antibodies; Autoimmunity; IL 17

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCATOR AUTOANTIBODY; AUTOANTIBODY; CD19 ANTIGEN; CREATINE KINASE MB; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 17 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE VIRAL MYOCARDITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD SAMPLING; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; COXSACKIE VIRUS B3; DISEASE COURSE; DRUG INHIBITION; ENZYME ACTIVITY; HEART; HEART WEIGHT; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; VIRUS MYOCARDITIS;

ADENINE NUCLEOTIDE TRANSLOCATOR 1; ANIMALS; ANTIBODIES, BLOCKING; AUTOANTIBODIES; B-LYMPHOCYTES; CELL PROLIFERATION; COXSACKIEVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS;

EID: 76849090425     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.11.010     Document Type: Article

References (30)

1. Fairweather D., and Rose N.R. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41 (2007) 118-122
2. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., and Rose N.R. From infection to autoimmunity. J Autoimmun 16 (2001) 175-186
3. Why H.J., Meany B.T., Richardson P.J., Olsen E.G., Bowles N.E., Cunningham L., et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89 (1994) 2582-2589
4. Liao Y.H. Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy. Int J Cardiol 54 2 (1996) 165-169
5. Liu P.P., and Mason J.W. Advances in the understanding of myocarditis. Circulation 104 9 (2001) 1076-1082
6. Fuse K., Chan G., Liu Y., Gudgeon P., Husain M., Chen M., et al. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112 (2005) 2276-2285
7. Opavsky M.A., Penninger J., Aitken K., Wen W.H., Dawood F., Mak T., et al. Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection. Circ Res 85 (1999) 551-558
8. Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9 (2003) 1484-1490
9. Cooper Jr. L.T. Myocarditis. N Engl J Med 360 (2009) 1526-1538
10. Rose N.R. Autoimmunity in coxsackievirus infection. Curr Top Microbiol Immunol 323 (2008) 293-314
11. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1133
12. Rangachari M., Mauermann N., Marty R.R., Dirnhofer S., Kurrer M.O., Komnenovic V., et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 203 (2006) 2009-2019
13. Chang H., Hanawa H., Yoshida T., Hayashi M., Liu H., Ding L., et al. Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer. Circ J 72 (2008) 813-819
14. Pernis A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 265 (2009) 644-652
15. Hsu H.C., Yang P., Wang J., Wu Q., Myers R., Chen J., et al. Interleukin 17-producing T helper cells and interleukin-17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9 (2008) 166-175
16. Doreau A., Belot A., Bastid J., Riche B., Trescol-Biemont M.C., Ranchin B., et al. Interleukin-17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10 (2009) 778-785
17. Nishio R., Matsumori A., Shioi T., Ishida H., and Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 100 (1999) 1102-1108
18. Liao Y.H., Yuan J., Wang Z.H., Cheng X., Zhang J.H., Tian Y., et al. Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice. J Clin Immunol 25 (2005) 376-384
19. Dörner A., Kallwellis-Opara A., Pauschinger M., Kühl U., and Schultheiss H.P. Cardiac autoantibodies in viral myocarditis. Heart Fail Clin 1 (2005) 333-343
20. Caforio A.L., Tona F., Bottaro S., Vinci A., Dequal G., Daliento L., et al. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41 (2008) 35-45
21. Schulze K., Witzenbichler B., Christmann C., and Schultheiss H.P. Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovasc Res 44 1 (1999) 91-100
22. Li J., Leschka S., Rutschow S., Schwimmbeck P.L., Husmann L., Noutsias M., et al. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis. Eur J Pharmacol 554 (2007) 60-68
23. Jiang Z., Xu W., Li K., Yue Y., Xu L., Ye F., et al. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer. J Gene Med 10 (2008) 918-929
24. Afanasyeva M., Wang Y., Kaya Z., Stafford E.A., Dohmen K.M., Sadighi Akha A.A., et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 104 (2001) 3145-3151
25. Eriksson U., Kurrer M.O., Sebald W., Brombacher F., and Kopf M. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol 167 (2001) 5464-5469
26. Cihakova D., and Rose N.R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv Immunol 99 (2008) 95-114
27. Nalbandian A., Crispín J.C., and Tsokos G.C. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157 (2009) 209-315
28. Cho Y.G., Cho M.L., Min S.Y., and Kim H.Y. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 7 (2007) 65-70
29. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., and van den Berg W.B. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50 (2004) 650-659
30. Uyttenhove C., and Van Snick J. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J Immunol 36 (2006) 2868-2874